Congenital Heart Disease and Impacts on Child Development

Mari, Mariana Alievi; Cascudo, Marcelo Matos; Alchieri, João Carlos

doi:10.5935/1678-9741.20160001

Cited by 38 publications

(21 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our study, the cyanotic showed the poor quality of life than acyanotic heart disease children; it supposed to be related to the difference in cognitive and nutritional status. Therefore, a multidisciplinary approach should be applied for early identification of those impairments to offer the best opportunity for treatment that may allow the child to reach the fullest potential in adulthood and minimize the negative impact on the quality of life and parents should be more aware and responsive to the development and nutrition aspect of their child [27].…”

Section: Discussionmentioning

confidence: 99%

Growth, Development, and Quality of Life in Children with Congenital Heart Disease Children

Maya¹,

Gunawijaya²,

Yantie³

et al. 2020

Open Access Maced J Med Sci

View full text Add to dashboard Cite

BACKGROUND: Despite the advances in medical and surgical care have improved the survival rates of children with congenital heart disease (CHD), they still remain risky for nutritional, cognitive problems, and quality of life. Those impacts vary according to the severity of heart lesions and still manifested years after surgery. AIM: The objective of this study was to compare growth, development, and quality of life between cyanotic and acyanotic CHD in 52 patients aged 24–69 months old from June to January 2018 in Sanglah Pediatric Cardiology clinic used WHO Anthro software, The Mullen Scales of Early Learning and PedsQL Cardiac module. RESULTS: We found significant different proportion of underweight 11.5% in acyanotic children, 42.3% in cyanotic by weight/age z-score <−2SD (p = 0.033). Height/ age z-score <−3SD 38.5% in cyanotic versus 11.5% in acyanotic (p = 0.025). The cyanotic showed a significant difference in cognitive function, presented by early learning composite score (p = 0.044) particularly in gross motor (p = 0.034) and receptive language (0.047). Quality of life differs significantly between both groups in heart problem and therapy (p = 0.042), treatment anxiety (p = 0.016), cognitive problems (p = 0.038), and communication (p = 0.022). CONCLUSION: Development, growth problems, and lower quality of life are common in cyanotic children, thus highlight the need for longitudinal surveillance.

show abstract

Section: Discussionmentioning

confidence: 99%

Growth, Development, and Quality of Life in Children with Congenital Heart Disease Children

Maya¹,

Gunawijaya²,

Yantie³

et al. 2020

Open Access Maced J Med Sci

View full text Add to dashboard Cite

show abstract

“…Congenital heart disease (CHD) represents a public health issue due to its high incidence of 9/1000 live births . Undernutrition may occur in up to 90% of these patients and may be related to poorer surgical and neurological outcomes . Nutrition recovery may take several months to occur after surgery, and there is evidence that these children may not recover stature, remaining shorter in height than expected…”

Section: Introductionmentioning

confidence: 99%

“…1 Undernutrition may occur in up to 90% of these patients 2 and may be related to poorer surgical and neurological outcomes. 3,4 Nutrition recovery may take several months to occur after surgery, and there is evidence that these children may not recover stature, remaining shorter in height than expected. 5 The complexity of this group of patients often causes insecurity when beginning the diet and also frequent interruptions in feeding, which will contribute to a lower energy supply.…”

Section: Introductionmentioning

confidence: 99%

Tolerability and Effects of the Use of Energy‐Enriched Infant Formula After Congenital Heart Surgery: A Randomized Controlled Trial

Scheeffer

Ricachinevsky

Freitas

et al. 2019

J Parenter Enteral Nutr

View full text Add to dashboard Cite

Background Undernutrition is a common problem among children with congenital heart disease (CHD) and may lead to poorer surgical outcomes. A higher intake of energy during the postoperative period of CHD surgery seems to be associated with better outcomes. This study aimed to investigate the effect of the use of energy‐enriched formula (EE‐formula) compared with normocaloric formula during 30 days after CHD surgery. Methods A randomized controlled trial with patients undergoing heart surgery in a tertiary hospital in southern Brazil from March 2017 to December 2017 was performed. The intervention group received EE‐formula (1 kcal/mL), and the control group received normocaloric formula (0.67 kcal/mL). The researcher in charge of anthropometric evaluation was blinded to the randomization. Results Fifty‐nine patients were included; 30 in control group and 29 in intervention group. There were no statistically significant differences between groups regarding age, gender, anthropometry, and surgical risk classification after randomization. A statistically significant difference in z‐score of weight for age and in weight gain variation rate between groups after intervention was observed. Antibiotic use was less frequent in the intervention group, and hospital length of stay was shorter. General gastrointestinal side effects were similar between groups, whereas diarrhea was more frequent in the intervention group. However, this side effect was limited and had spontaneous resolution in 4 out of 6 cases. Conclusion This study demonstrates that EE‐formula use after heart surgery of patients with CHD is well tolerated and may improve short‐term nutrition outcome, decrease hospital stay, and reduce antibiotic use.

show abstract

“…Las intervenciones en rehabilitación cardiaca pueden minimizar los efectos negativos a nivel motor y en la capacidad funcional, al igual que fomentar y hacer que el ambiente del infante o del adolescente sea favorable al desarrollo de sus habilidades. (Mari, Cascudo, & Alchieri , 2016)…”

Section: Rehabilitación Cardiaca En El Infante Y Adolescente Con Cardunclassified

Rehabilitación cardíaca en el infante y adolescente con cardiopatía congénita corregida

Castillo

2019

Mov. cient.

View full text Add to dashboard Cite

Las cardiopatías congénitas son definidas como anormalidades estructurales importantes del corazón o de los grandes vasos intra-torácicos, que tienen actualmente o potencialmente significancia funcional. Estos defectos generalmente son el resultado de anomalías embrionarias en el desarrollo de la estructura cardiovascular. La etiología de las cardiopatías congénitas es variable en la mayoría de los casos, la causa es considerada multifactorial como resultado de la interacción entre los genes y el ambiente. En Colombia, las cardiopatías congénitas constituyen la tercera causa de anormalidad congénita después del síndrome de Down y los trastornos asociados con paladar hendido. Esta revisión bibliográfica tiene como objetivo hacer una propuesta descriptiva sobre el proceso de rehabilitación cardiaca en la cardiopatía congénita corregida en el infante o adolescente. Metodología: Se realizó una búsqueda bibliográfica de artículos científicos entre los años 2013 y 2017 en general, mediante el uso del buscador scholar.google.es (google académico), usando como enunciados de búsqueda cardiopatía congénita, rehabilitación cardiaca en cardiopatías congénitas, intervención en la cardiopatía congénita. Conclusión: Son ampliamente conocidos los beneficios del programa de rehabilitación cardiaca que está dirigido al adulto con cardiopatía o enfermedad crónica no trasmisibles, pero son pocas las guías o protocolos propuestos para la intervención en infantes o adolescentes con cardiopatía congénita corregida. Así mismo, se deben entregar aportes desde la fisioterapia desde la evaluación inicial, prescripción del ejercicio especifico, monitorización del ejercicio, prevención de complicaciones y demás herramientas para llevar a cabo un buen proceso de rehabilitación cardiaca en el infante y adolescente con cardiopatía congénita corregida.

show abstract

Congenital Heart Disease and Impacts on Child Development

Cited by 38 publications

References 16 publications

Growth, Development, and Quality of Life in Children with Congenital Heart Disease Children

Growth, Development, and Quality of Life in Children with Congenital Heart Disease Children

Tolerability and Effects of the Use of Energy‐Enriched Infant Formula After Congenital Heart Surgery: A Randomized Controlled Trial

Rehabilitación cardíaca en el infante y adolescente con cardiopatía congénita corregida

Contact Info

Product

Resources

About